[Novartis Foundation Symposia] Defining Optimal Immunotherapies for Type 1 Diabetes (Novartis Foundation Symposium 292) || General Discussion III
Bock, Gregory, Goode, JamieVolume:
10.1002/97
Year:
2008
Language:
english
DOI:
10.1002/9780470697405.ch13
File:
PDF, 144 KB
english, 2008